Susanne Schultze-Seemann
Has participated in:
-
Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer
-
An anti-PSMA immunotoxin reduces Mcl-1 and Bcl2A1 and specifically induces in combination with the BAD-like BH3 mimetic ABT-737 apoptosis in prostate cancer cells
-
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
-
Synergistic cytotoxicity of a toxin targeting the epidermal growth factor receptor and the glycosylated triterpenoid SO1861 in prostate cancer